Irinotecan Hydrochloride
- Product NDC
- 68001-284
- 11-digit product format
- 680010284
- Labeler code
- 68001
- Product ID
- 68001-284_952bfc0f-6e66-426f-b3d5-7d9d6e81b8ad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irinotecan Hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- BluePoint Laboratories
- Application
- ANDA077219
- Marketing category
- ANDA
- Marketing start
- 2008-02-20
- Marketing end
- 0000-00-00
- Substance
- IRINOTECAN HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-284-25 | 68001028425 | 1 VIAL in 1 CARTON (68001-284-25) > 5 mL in 1 VIAL (68001-284-22) | 1 vial | 2016-05-31 | 0000-00-00 | No | No | Current |
| 68001-284-34 | 68001028434 | 1 VIAL in 1 CARTON (68001-284-34) > 2 mL in 1 VIAL (68001-284-35) | 1 vial | 2016-05-31 | 0000-00-00 | No | No | Current |